Figure 1
From: Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
Representative images of FISH- and IHC findings in gastric cancer. a-h) Examples of amplified and non-amplified cancers: a, b) HER2, c, d) EGFR, e, f) CCND1 and g, h) MYC. i-l): Examples of HER2-immunohistochemistry negative (score 0–1, i, j) and positive (score 2–3, k, l) cancers.